Paper
18 June 2004 Investigation of doxorubicin for multidrug resistance using a fluorescent cytometric imaging system integrated onto cell culture analog devices
Donghyun Kim, Hui Xu, Sung June Kim, Michael L. Shuler
Author Affiliations +
Abstract
An integrated cytometric fluorescent imaging system is developed for characterizing chemical concentration and cellular status in microscale cell culture analog (μCCA) devices. A μCCA is used to evaluate the potential toxicity and efficacy of proposed pharmaceutical treatment of animals or humans. The imaging system, based on discrete optical components, not only provides a robust and compact tool for real-time measurements, but the modularity of the system also offers flexibility to be applicable to various μCCA structures that may be appropriate to various animal or human models. We investigate the dynamics of doxorubicin, a chemotherapeutic agent, on cultured cells in a μCCA using the integrated cytometric fluorescent imaging system. This study incorporates two uteran cancer cell lines representing a sensitive cell type and a multi-drug resistant (MDR) derivative cell line. The ultimate goal is to test the effect of MDR modulators in combination with doxorubicin to kill cancer cells while not causing undue harm to normal cells.
© (2004) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Donghyun Kim, Hui Xu, Sung June Kim, and Michael L. Shuler "Investigation of doxorubicin for multidrug resistance using a fluorescent cytometric imaging system integrated onto cell culture analog devices", Proc. SPIE 5325, Optical Diagnostics and Sensing IV, (18 June 2004); https://doi.org/10.1117/12.523626
Lens.org Logo
CITATIONS
Cited by 4 patents.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Simulation of CCA and DLA aggregates

Imaging systems

Analog electronics

Optical components

Modulators

Resistance

Cancer

Back to Top